Astellas Pharma Inc 2011 SR
The report outlines Astellas Pharma's CSR-based management, focusing on five fields: employees, society, environment, economy, and compliance. Key highlights include the acquisition of OSI Pharmaceuticals, the launch of the 'Changing Tomorrow Day' global volunteer initiative, and the introduction of a new biodiversity index to quantify environmental impact. The company achieved a 18.9% reduction in global greenhouse gas emissions compared to fiscal 2005 levels. It also details efforts in urology, oncology, and transplantation, alongside initiatives for work-life balance and product safety.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2011
Type: SR
Pages: 34
Back to company
Astellas Pharma Inc
CSR Report
The report outlines Astellas Pharma's CSR-based management, focusing on five fields: employees, society, environment, economy, and compliance. Key highlights include the acquisition of OSI Pharmaceuticals, the launch of the 'Changing Tomorrow Day' global volunteer initiative, and the introduction of a new biodiversity index to quantify environmental impact. The company achieved a 18.9% reduction in global greenhouse gas emissions compared to fiscal 2005 levels. It also details efforts in urology, oncology, and transplantation, alongside initiatives for work-life balance and product safety.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2011
Reporting Period
Apr 1, 2010 - Mar 31, 2011
Fiscal Year
2011
Published
Oct 1, 2011
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees